Contact: Bryan Goodman, (202) 997-1606   
Email: bryan_boodman@americanchemistry.com

WASHINGTON (March 13, 2015) - Today members of the UN Commission on Narcotic Drugs unanimously rejected the recommendation from the World Health Organization to list 1,4-butanediol (BDO) and gamma-butyrolactone (GBL) as Schedule I substances under the 1971 Convention on Psychotropic Substances. In response to these developments, the American Chemistry Council released the following statement.  

"The UN Commission on Narcotic Drugs has unanimously rejected the recommendation from the WHO to list the industrial chemicals GBL and BDO‎ as Schedule I substances under the 1971 Convention on Psychotropic Substances. In fact, the 53 delegates unanimously agreed to not even bring the matter to a formal vote. As the delegates noted, such a classification would have severe economic consequences, disrupt many crucial industries, and affect country development agendas across the global economy.

"We support this decision in recognition of the strong product stewardship initiatives and controls that  ACC member companies already have in place for these substances."

» Learn more about butanediol and gamma-butyrolactone

News

News & Resources

View our resource center to find press releases, testimonies, infographics and more.

Jobs

Jobs and Economic Impact

The business of chemistry provides 811,000 skilled, good-paying American jobs—earning 44 percent more than the average manufacturing pay.